Itolizumab
- All
- News
- Videos
-
Biocon Says Clinical Study For Drug Itolizumab Initiated After Drug Regulator's Approval
Biocon Biologics, an arm of biotechnology major Biocon, on Thursday said clinical study for its biologic drug Itolizumab for possible indication in autoimmune disease Lupus Nephritis has been initiated in India after approval from the Drugs C
-
Psoriasis Injection Cleared For Limited Use To Treat COVID Patients: Drug Controller
India's drug regulator has approved Itolizumab, a drug used to cure skin ailment psoriasis for "restricted emergency use" to treat COVID-19 patients with moderate to severe acute respiratory distress, officials told PTI on Friday.
-
Biocon Says Clinical Study For Drug Itolizumab Initiated After Drug Regulator's Approval
Biocon Biologics, an arm of biotechnology major Biocon, on Thursday said clinical study for its biologic drug Itolizumab for possible indication in autoimmune disease Lupus Nephritis has been initiated in India after approval from the Drugs C
-
Psoriasis Injection Cleared For Limited Use To Treat COVID Patients: Drug Controller
India's drug regulator has approved Itolizumab, a drug used to cure skin ailment psoriasis for "restricted emergency use" to treat COVID-19 patients with moderate to severe acute respiratory distress, officials told PTI on Friday.
